Literature DB >> 33613817

Efficacy of Traditional Chinese Medicine on COVID-19: Two Case Reports.

Zi Zhou Zheng1, Ning Ning Ma1, Lily Li2, Dan Jiang3,4.   

Abstract

Severe acute respiratory syndrome coronavirus 2-infected pneumonia (novel coronavirus-infected pneumonia [NCIP]) is a new viral illness initially identified in the central Chinese city of Wuhan in December 2019. According to the daily report on the epidemic situation of coronavirus disease (COVID-19) issued by the National Health and Family Planning Commission of the People's Republic of China on March 23, 2020: COVID-19 is highly infectious, causing extremely high incidence of NCIP throughout Wuhan and has spread swiftly to 34 provinces within China and >100 other countries around the world between January and March 2020. Up to August 11, 2020, there have been 89,383 cases diagnosed as coronavirus-infected pneumonia; and 4,696 deaths in China (mortality rate of 5.25%) and worldwide reports have confirmed 19,936,210 cases and 732,499 deaths. These figures have been increasing daily. The treatment of viral conditions is well established within the context of Chinese Medicine. We report 2 successful cases in this study showing the patient's chest computed tomography scans and temperature charts made on before, during, and after treatment to demonstrate proof of the positive benefits achieved. Traditional Chinese Medicine (TCM) demonstrates a positive effect in the treatment for COVID-19. It is highly recommended that TCM be incorporated early on in the treatment schedule for COVID-19. Copyright 2021, Mary Ann Liebert, Inc., publishers.

Entities:  

Keywords:  COVID-19; Traditional Chinese Medicine; novel coronavirus-infected pneumonia; respiratory disorders; severe acute respiratory syndrome coronavirus 2

Year:  2021        PMID: 33613817      PMCID: PMC7894045          DOI: 10.1089/acu.2020.1432

Source DB:  PubMed          Journal:  Med Acupunct        ISSN: 1933-6586


  7 in total

1.  [Effect of glucocorticoid with traditional Chinese medicine in severe acute aespiratory syndrome (SARS)].

Authors:  Bao-yan Liu; Li-yun He; Zhi-wei Liang; Xin-yuan Tong; Jing-qing Hu; Qiang Jiao; Qing Ni; Xi-ming Liu; Yan-ming Xie; Ping Li; Fan-zhu Gao; Tian-cai Wen; Wei-min Liu
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  2005-12

2.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

3.  [Determination of ephedrine hydrochloride, pseudoephedrine hydrochloride and methylephedrine hydrochloride in maxingshigan decoction by CE].

Authors:  Li-ping Yu; Xiao-ke Wang; Jia-bo Luo
Journal:  Zhong Yao Cai       Date:  2011-04

4.  The use of an herbal formula by hospital care workers during the severe acute respiratory syndrome epidemic in Hong Kong to prevent severe acute respiratory syndrome transmission, relieve influenza-related symptoms, and improve quality of life: a prospective cohort study.

Authors:  Joseph T F Lau; P C Leung; E L Y Wong; C Fong; K F Cheng; S C Zhang; C W K Lam; V Wong; K M Choy; W M Ko
Journal:  J Altern Complement Med       Date:  2005-02       Impact factor: 2.579

5.  Posttreatment with Ma-Xing-Shi-Gan-Tang, a Chinese medicine formula, ameliorates lipopolysaccharide-induced lung microvessel hyperpermeability and inflammatory reaction in rat.

Authors:  Li-Qian Ma; Chun-Shui Pan; Ning Yang; Yu-Ying Liu; Li Yan; Kai Sun; Xiao-Hong Wei; Ke He; Meng-Meng Xiao; Jing-Yu Fan; Jing-Yan Han
Journal:  Microcirculation       Date:  2014-10       Impact factor: 2.628

6.  [Clinical manifestation, treatment, and outcome of severe acute respiratory syndrome: analysis of 108 cases in Beijing].

Authors:  Chun-hui Zhao; Yan-bin Guo; Hao Wu; Xiu-hui Li; Xin-hui Guo; Rong-hua Jin; Hui-guo Dign; Qing-hua Meng; Zhen-wei Lang; Wei Wang; Hui-ping Yan; Chun Huang; De-gong Liu
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2003-06-10

7.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

  7 in total
  3 in total

Review 1.  Actional Mechanisms of Active Ingredients in Functional Food Adlay for Human Health.

Authors:  Yawen Zeng; Jiazhen Yang; Jia Chen; Xiaoying Pu; Xia Li; Xiaomeng Yang; Li'e Yang; Yumei Ding; Mingying Nong; Shibao Zhang; Jinbao He
Journal:  Molecules       Date:  2022-07-27       Impact factor: 4.927

2.  Integrated therapeutic plasma exchange and traditional Chinese medicine treatment in a patient with severe COVID-19: A case report.

Authors:  Chia-Wei Lin; Wei-Chen Hsu; Chien-Lu Lu; Su-Hsing Cheng; Cheng-Pin Chen; Yu-Chang Hou
Journal:  J Integr Med       Date:  2022-09-03

3.  Repurposing Siddha mercurial drug for mild to moderate COVID-19 - Case series and exploration of its chemical profile.

Authors:  Saravana Shiva; Shanmugam Mari; Arul Amuthan; Ramalingam Shanmugam
Journal:  J Ayurveda Integr Med       Date:  2021-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.